Luminor Medical Technologies Inc. announced that the Shareholder Meeting saw three new additions to the Board of Directors including Mr. Chris Dollard, Ms. Constance Finley and Mr. Michael Campbell. Mr. Dollard is COO of RISE Life Science Corp. Previously, he served as COO of RISE Research Inc. since its inception in the fall of 2015. He also brings to RISE Life Science Corp. a wealth of knowledge and experience from his work related to
operational planning and facility design pertaining to early cannabis producer applications. Finley is the founder and President of Constance Therapeutics, a San Francisco-based company that produces whole plant medicinal cannabis extracts for physicians and their patients. Mr. Campbell is General Counsel and Corporate Secretary of Intellipharmaceutics International Inc. He previously served as General Counsel for Griffis Capital and Canada Cartage System L.P. It was also announced that Mr. Harry Bloomfield, who has served as Chairperson of Luminor Medical Technologies Board of Directors, has retired from the Board. Anton Mattadeen has been elected as Chairperson of the Board of Directors. RISE Life Science Corp. announced that Robert Lelovic CPA, CA has joined the company as Chief Financial Officer. Mr. Lelovic replaces Chris Carmichael who has filled this role during the transition period from Luminor to RISE Life Science Corp. Mr. Lelovic graduated from York University in 1998 and has been a chartered accountant since 2001. He has extensive experience in public company reporting, corporate governance and compliance. Mr. Lelovic is the president of Robert Lelovic Professional Corporation, a company registered with the Institute of CPA Ontario and the co-founder of Inlync.